BME100 s2015:Group1 9amL1

From OpenWetWare

Jump to: navigation, search
BME 100 Spring 2015 Home
People
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Photos
Wiki Editing Help
Image:BME494_Asu_logo.png


Contents

OUR TEAM

Name: Shawn Striker
Name: Shawn Striker
Name: Jonathan Moreno
Name: Jonathan Moreno
Name: Grace Kim
Name: Grace Kim
Name: Your name
Name: Your name
Name: Your name
Name: Your name
Name: Your name
Name: Your name

LAB 1 WRITE-UP

Independent and Dependent Variables

Independent variable: Lipopolysaccharide
Dependent variable: Protein Inflammotin

Experimental Design

Groups
Control Group: The control group will receive a placebo on a regular basis coinciding with the prescribed drug regimen.

Experimental Groups:
Group 1 (Control): 0 mg
Group 2: 2.5mg
Group 3: 5mg
Group 4: 7.5mg
Group 5: 10mg

Age
70-80


Number of subjects per group

100 subjects total per group; 50 male and 50 female




Subject Selection

Healthy (no history of alcohol or drug use, no sickness/chronic diseases, healthy weight)
70-80 years, absence of drug history that affects inflammotin.





Sources of Error and Bias

Other drugs being used, subjects' genetic predisposition, amount of inflammotin in the body prior to tests.
Consideration of the effect of the drug due to the initial amount of inflammotin.







Personal tools